EMERYVILLE,
Calif., March 11,
2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq:
AMRS), a leading synthetic biotechnology company accelerating the
world's transition to sustainable consumption through its
Lab-to-Market™ technology platform today announced that it has
closed the acquisition of the assets of MenoLabs, LLC, a company
founded by women to treat menopause symptoms, drive research for
women's health and improve society's understanding of
menopause.
MenoLabs, a growing women's wellness brand, is focused on
addressing perimenopause and menopause symptoms and offers
research-backed, all-natural treatments for menopause symptoms.
Over the past two years, MenoLabs has developed and launched eight
products, including its lead product, MenoFit, an all-natural
menopause relief supplement. MenoLabs generates a
subscription-based, recurring revenue stream through its online
sales, in addition to the Subscribe & Save option offered via
the Amazon channel. The company is further expanding through retail
channels in 2022. Additionally, MenoLabs offers MenoLife, a highly
rated perimenopause and menopause health tracker app which helps
users track and analyze more than 40 menopause-related
symptoms.
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-Market™ technology platform. This Amyris platform
leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products. For more information, please visit
http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
About MenoLabs
MenoLabs was founded to
fundamentally change how menopause is addressed. The brand's
mission is to provide options to treat menopause symptoms, drive
research for women's health and change how society approaches,
views and educates around the topic of menopause. MenoLabs
has developed a line of all natural, proprietary supplements
focused on treating perimenopause and menopause
symptoms, in addition to MenoLife, a leading menopause
health tracker app that provides women a voice and
community. MenoLife also provides symptom tracking to
further fuel research and advancements in women's
health.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-closes-acquisition-of-menolabs-301500717.html
SOURCE Amyris, Inc.